{"code":"M61.2","type":"code","title":"Paralytic calcification and ossification of muscle","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":[],"excludes1":["dermatopolymyositis (M33.-)","myopathy in amyloidosis (E85.-)","myopathy in polyarteritis nodosa (M30.0)","myopathy in rheumatoid arthritis (M05.32)","myopathy in scleroderma (M34.-)","myopathy in Sjögren's syndrome (M35.03)","myopathy in systemic lupus erythematosus (M32.-)"],"excludes2":["muscular dystrophies and myopathies (G71-G72)"],"isBillable":false,"fyEffectivity":{"fy2026":true,"fy2027":true},"sibling_codes":["M61.20","M61.21","M61.211","M61.212","M61.219","M61.22","M61.221","M61.222","M61.229","M61.23","M61.231","M61.232","M61.239","M61.24","M61.241","M61.242","M61.249","M61.25","M61.251","M61.252","M61.259","M61.26","M61.261","M61.262","M61.269","M61.27","M61.271","M61.272","M61.279","M61.28","M61.29"],"inclusionTerms":["Myositis ossificans associated with quadriplegia or paraplegia"],"sibling_titles":{"code":"M61.29","title":"Paralytic calcification and ossification of muscle, multiple sites","isBillable":true},"useAdditionalCode":[],"clinicalDefinition":"Paralytic calcification and ossification of muscle is a non-billable ICD-10-CM category code (M61.2). A more specific billable subcode must be selected for claims submission. Inclusion terms: Myositis ossificans associated with quadriplegia or paraplegia. Excludes1 (not coded here): dermatopolymyositis (M33.-); myopathy in amyloidosis (E85.-); myopathy in polyarteritis nodosa (M30.0); myopathy in rheumatoid arthritis (M05.32); myopathy in scleroderma (M34.-); myopathy in Sjögren's syndrome (M35.","officialDefinition":"Paralytic calcification and ossification of muscle is a non-billable ICD-10-CM category code (M61.2). A more specific billable subcode must be selected for claims submission. Inclusion terms: Myositis ossificans associated with quadriplegia or paraplegia. Excludes1 (not coded here): dermatopolymyositis (M33.-); myopathy in amyloidosis (E85.-); myopathy in polyarteritis nodosa (M30.0); myopathy in rheumatoid arthritis (M05.32); myopathy in scleroderma (M34.-); myopathy in Sjögren's syndrome (M35.03); myopathy in systemic lupus erythematosus (M32.-). Excludes2 (not included here): muscular dystrophies and myopathies (G71-G72).","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}